Impact of Online Patient Feedback (OQ) to Therapist

NCT ID: NCT01891045

Last Updated: 2024-01-24

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

160 participants

Study Classification

INTERVENTIONAL

Study Start Date

2011-07-01

Study Completion Date

2023-01-03

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Dropout represents one of the largest problems in substance abuse treatment. International and Nordic research show that only 20 - 40 % of substance abusers complete treatment as intended. At the same time, one of the most consistent factors of favourable post-treatment outcome is treatment completion. In spite of the serious and continuous challenge dropout represents the phenomena is not well understood and there is a need to explore more of the factors that influence dropout and how it can be counteracted. As also stated: "…effective methods for reducing the problem of dropouts from treatment is one more area in need of further research" (NOU 2003:4, s 77).

For the general field of mental health one of the most important innovations involves providing therapists with patient feedback about their progress. The most well-established and widely researched feedback system is the Outcome Questionnaire (OQ-45.2). The system has been shown to improve treatment outcomes, including reduced treatment dropout and length of treatment, but the system is yet to be utilized with a substance abusing patient group. The aim of the present study is to examine the usefulness of OQ-45.2 with substance abusing patients.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Hypotheses and research questions

1\. The OQ-45.2 feedback will be effective in identifying patients at risk of dropout of substance abuse treatment.

1a. The condition were feedback is withheld from the therapist, will correctly identify patients who will dropout.

Research Question: Is there variation in the accuracy of dropout prediction as a function of age, gender differences or type of substance abuse?

2\. The OQ-45.2 feedback will be effective in reducing dropout in outpatient substance abuse treatment.

2a. The feedback condition will result in less dropout than the no-feedback condition.

Research Question: Is there a variation in the OQ-45.2 preventive dropout effect due to age, gender or type of substance abuse?

3\. The OQ-45.2 feedback will shorten length of inpatient substance abuse treatment.

3a. The feedback condition will identify patients who are ready to terminate therapy.

Research Question: Is there variation in identification of patients ready to terminate as a function of age, gender differences or type of substance abuse?

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Drug Addiction Drug Abuse

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Control

Patients merely monitored on background variables to function as a baseline of comparison

Group Type NO_INTERVENTION

No interventions assigned to this group

Prediction

Patients randomized to this condition completes the OQ-45.2 weekly, but the reports are withheld from therapists and patients.

Group Type ACTIVE_COMPARATOR

OQ-45.2 no feedback

Intervention Type BEHAVIORAL

Completion of the OQ-45.2 before each session, but no feedback to therapists or patients

Intervention

Patients and therapists uses the feedback-system as intended, with real-time feedback to the therapist and full use of the suggested interventions

Group Type EXPERIMENTAL

OQ-45.2

Intervention Type BEHAVIORAL

Completion of the OQ-45.2 with real-time feedback to the therapist and full use of the suggested interventions every week of the treatment program

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

OQ-45.2 no feedback

Completion of the OQ-45.2 before each session, but no feedback to therapists or patients

Intervention Type BEHAVIORAL

OQ-45.2

Completion of the OQ-45.2 with real-time feedback to the therapist and full use of the suggested interventions every week of the treatment program

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Primary diagnosis of addiction, F10-19, using the International Classification of Diseases, admitted in 2011-2014 for treatment at the department of addiction treatment - youth, Oslo University Hospital

Exclusion Criteria

* Ongoing psychoses, severe language difficulties
Minimum Eligible Age

16 Years

Maximum Eligible Age

26 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of Oslo

OTHER

Sponsor Role collaborator

Oslo University Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Espen Walderhaug

PhD

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Department of addiction treatment- youth

Oslo, , Norway

Site Status

Oslo University Hospital - Department of addiction treatment youth

Oslo, , Norway

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Norway

References

Explore related publications, articles, or registry entries linked to this study.

Amble I, Gude T, Stubdal S, Oktedalen T, Skjorten AM, Andersen BJ, Solbakken OA, Brorson HH, Arnevik E, Lambert MJ, Wampold BE. Psychometric properties of the outcome questionnaire-45.2: the Norwegian version in an international context. Psychother Res. 2014;24(4):504-13. doi: 10.1080/10503307.2013.849016. Epub 2013 Nov 5.

Reference Type RESULT
PMID: 24188797 (View on PubMed)

Brorson HH, Arnevik EA, Rand K. Predicting Dropout from Inpatient Substance Use Disorder Treatment: A Prospective Validation Study of the OQ-Analyst. Subst Abuse. 2019 Aug 15;13:1178221819866181. doi: 10.1177/1178221819866181. eCollection 2019.

Reference Type RESULT
PMID: 31452601 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

OQ45-11-1

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Monitoring and Feedback in Substance Abuse Treatment
NCT01465490 COMPLETED PHASE1/PHASE2